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Nestinþ cells direct inﬂammatory cell migration
in atherosclerosis
Raquel del Toro1,2, Raphael Che`vre1, Cristina Rodrı´guez3, Antonio Ordo´n˜ez2, Jose´ Martı´nez-Gonza´lez3,
Vicente Andre´s1 & Simo´n Me´ndez-Ferrer1,4
Atherosclerosis is a leading death cause. Endothelial and smooth muscle cells participate in
atherogenesis, but it is unclear whether other mesenchymal cells contribute to this process.
Bone marrow (BM) nestinþ cells cooperate with endothelial cells in directing monocyte
egress to bloodstream in response to infections. However, it remains unknown whether
nestinþ cells regulate inﬂammatory cells in chronic inﬂammatory diseases, such as ather-
osclerosis. Here, we show that nestinþ cells direct inﬂammatory cell migration during chronic
inﬂammation. In Apolipoprotein E (ApoE) knockout mice fed with high-fat diet, BM nestinþ
cells regulate the egress of inﬂammatory monocytes and neutrophils. In the aorta, nestinþ
stromal cells increase B30 times and contribute to the atheroma plaque. Mcp1 deletion in
nestinþ cells—but not in endothelial cells only— increases circulating inﬂammatory cells, but
decreases their aortic inﬁltration, delaying atheroma plaque formation and aortic valve
calciﬁcation. Therefore, nestin expression marks cells that regulate inﬂammatory cell
migration during atherosclerosis.
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A
therosclerosis is a progressive chronic inﬂammatory
disease characterized by the accumulation of leukocytes
and cholesterol in the artery wall. It is initiated with the
activation of endothelial cells, which recruit circulating inﬂam-
matory neutrophils and monocytes through adhesion molecules,
like ICAM1 and VCAM1 (refs 1,2), and increase the permeability
for low-density lipoproteins (LDL) and other lipids, which also
stimulate inﬂammatory inﬁltration3. Mice lacking Apolipoprotein
E (ApoE) develop hypercholesterolaemia and atherosclerosis,
more pronouncedly under high-fat diet (HFD)4,5. The chemokine
monocyte chemotactic protein-1 (Mcp1) promotes leukocyte
inﬁltration in the artery wall6. Inﬁltrated monocytes differentiate
into macrophages, which engulf oxidized LDL and other lipids,
becoming foam cells7. This process leads to the formation of the
atheroma plaque, which enlarges as vascular cells proliferate and
migrate from the media and the adventitia to the intima, where
they produce the interstitial collagen and elastin that forms
the ﬁbrous cap. At advanced stages, this cap becomes fragile8
and sometimes calciﬁed9. Plaque rupture induces blood coagu-
lation, which can cause thrombosis, the major risk of
atherosclerosis10.
Several studies have suggested that inﬂammatory cells can
inﬁltrate the artery wall not only through the intima, but also
through the adventitia11,12. Inﬂammatory inﬁltration is thus
facilitated by the formation of a microvascular network called
vasa vasorum, which provides oxygen and nutrients to the
adventitia and the media13. In turn, inﬂammation can promote
neovascularization, associated with bad prognosis and arterial
occlusion14–20. Recent studies have suggested the presence of
progenitors of endothelial and smooth muscle cells residing in the
vascular wall21,22. Sca1þ cells isolated from the adventitia can
differentiate into smooth muscle cells and endothelial cells, and
contribute to atherosclerosis23. Conversely, another recent study
showed that smooth muscle cells in the atheroma plaque can
exhibit phenotypes of other cell lineages, including mesenchymal
stem/progenitor cells (MSCs)24. Whereas stromal cells residing in
the artery wall might exhibit certain degree of plasticity and
contribute to atherogenesis, their crosstalk with inﬂammatory
cells is only partially understood, and it remains unclear whether
MSCs in the bone marrow (BM) and/or the aorta can directly
regulate the trafﬁc of inﬂammatory cells in chronic inﬂammatory
diseases, such as atherosclerosis.
Monocytes and other inﬂammatory cells, such as neutrophils,
are mainly produced in the BM. In response to pro-inﬂammatory
cytokines or pathogens, monocytes egress from the BM, circulate
and home to peripheral tissues, where they differentiate into
macrophages and dendritic cells25. Only recently have the
mechanisms that drive this directed migration began to be
elucidated. One mechanism underlying the response to acute
inﬂammation caused by infections involves MSCs expressing the
intermediate ﬁlament protein nestin26, which cooperate with
endothelial cells in directing the egress of inﬂammatory
monocytes from the BM to circulation27. Mcp1 regulates the
migration of these and other inﬂammatory cells through the
CCR2 receptor expressed in monocytes, neutrophils and myeloid
cells28. Some BM endothelial cells express nestin29,30, but it is
unclear whether this expression is associated with specialized
properties and functions.
In this study, we used a genetic approach to study side-by-side
the role of endothelial cells and MSCs in the trafﬁc of
inﬂammatory cells and the formation of plaques in athero-
sclerosis. Mcp1 deletion in nestinþ cells—but not in endothelial
cells—increased BM egress of inﬂammatory cells, but reduced
inﬂammatory inﬁltration in the aorta and signiﬁcantly delayed
atheroma plaque formation and aortic valve calciﬁcation. These
results suggest that nestinþ stromal cells contribute to directed
trafﬁc of inﬂammatory cells in different tissues during chronic
inﬂammation.
Results
BM nestinþ cells regulate inﬂammatory cell trafﬁc. First, we
studied the contribution of nestinþ stromal cells and endothelial
cells to BM egress of inﬂammatory cells in atherosclerosis. We
measured the expression of key adhesion molecules and chemo-
kines in atherosclerosis in BM CD45 Ter119 CD31 stromal
cells (BMSCs) and CD45 Ter119 CD31þ endothelial cells
(BMECs) isolated by ﬂuorescence-activated cell sorting (FACS)
from mice deﬁcient in Apolipoprotein E (ApoE / ) fed with
chow diet or with HFD, to boost atherogenesis (Fig. 1a). The
expression of the adhesion molecules Icam1 and Vcam1—required
for trans-endothelial leukocyte migration2—was induced similarly
in BMSCs and BMECs under HFD. In contrast, the induction of
Mcp1 expression was B30-fold higher in BMSCs (Fig. 1b),
suggesting a possible role for BMSCs in regulating inﬂammatory
monocyte migration in atherosclerosis.
To dissect the contribution of each cell population, we
selectively deleted Mcp1 in BMSCs and BMECs. Compared with
other BM cells, BMSCs are enriched in the expression of the
intermediate ﬁlament protein nestin26. We bred mice expressing
the green ﬂuorescent protein (GFP) under the regulatory
elements of nestin promoter (Nes-gfp)31 with ApoE / mice4.
In compound mice, BM CD45 Ter119 GFPþ cells comprised
B80% BMSCs andB20% BMECs (Fig. 1c). We deleted Mcp1 in
BMSCs using a transgenic mouse line expressing the inducible
CreERT2 recombinase under the regulatory elements of the Nestin
promoter (Nes-creERT2)32 bred to Mcp1-ﬂoxed mice27. For
comparison, we also deleted Mcp1 speciﬁcally in endothelial
cells using a line expressing CreERT2 under the regulatory
elements of endothelial vascular cadherin (Cdh5-creERT2)33.
Both Cre lines were intercrossed with ApoE-deﬁcient mice
to generate Nes-creERT2;Mcp1f/f;ApoE / mice, Cdh5-creERT2;
Mcp1f/f;ApoE / mice and control Mcp1f/f;ApoE / mice. We
treated both groups of mice with tamoxifen (to induce Cre
recombinase) and fed them with HFD for 8 weeks (Fig. 1d).
We measured circulating CD11bþ Ly6Clow and CD11bþ
Ly6C non-classical monocytes, CD11bþ Ly6Chigh inﬂamma-
tory monocytes and CD11bþ Ly6Ghigh inﬂammatory neutro-
phils, soon after tamoxifen administration (3 days), or 4 and 8
weeks after feeding the mice with HFD (Fig. 1e–h). Mcp1 deletion
in nestinþ cells rapidly and transiently increased the number of
circulating inﬂammatory monocytes and neutrophils, whereas
Mcp1 deletion in endothelial cells appeared to have the opposite
effect (Fig. 1g,h). This was not explained by differential
dyslipidemia, since the plasma concentration of cholesterol,
low- and high-density lipoproteins remained unchanged
(Supplementary Fig. 1a). These changes reﬂected an altered
trafﬁcking pattern of inﬂammatory cells, rather than proliferation
of inﬂammatory cells in lymphoid organs; after 8–12 weeks of
HFD, the number of inﬂammatory monocytes and neutrophils
was unchanged in BM or spleen, which also showed
a normal histological appearance (Supplementary Fig. 1b–e).
Also, Mcp1 deletion in nestinþ cells did not alter the inﬁl-
tration of inﬂammatory cells in other organs, such as the
lung and the liver (Supplementary Fig. 1f,g). Similarly,
Cdh5-creERT2;Mcp1f/f;ApoE / mice also had normal numbers
of splenocytes and BM nucleated cells, inﬂammatory monocytes
and inﬂammatory neutrophils (Supplementary Fig. 2). The
proliferation of macrophages locally in the atheroma plaque
may represent an additional source of inﬂammatory cells in
atherosclerosis34. We performed F4/80 staining in the aortic
valves of Nes-creERT2;Mcp1f/f;ApoE / mice and control
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Figure 1 | Nestinþ cells regulate inﬂammatory cell trafﬁc in atherosclerosis. (a) Flow cytometry plots showing the cell sorting strategy. (b) QPCR
analysis of Icam1, Vcam1 andMcp1mRNA in BM CD45 Ter119 CD31þ endothelial cells (BMEC) and BM CD45 Ter119 CD31 stromal cells (BMSC)
from ApoE / mice fed with chow or HFD for 2 months (n¼ 3–7). (c) CD31 expression in BM GFPþ stromal cells from Nes-gfp;ApoE / mice fed with
HFD for 2–3 months (n¼4). (d) Experimental design of peripheral blood analysis from mice treated with tamoxifen and fed with HFD for 2 months.
(e,f) Flow cytometry strategy used to identify inﬂammatory neutrophils, inﬂammatory monocytes and non-classical monocytes. (g,h) Number of non-
classical monocytes, inﬂammatory monocytes and inﬂammatory neutrophils in the peripheral blood of tamoxifen-treated (g) Nes-CreERT2;Mcp1f/f;ApoE /
mice, (h) Cdh5-CreERT2;Mcp1f/f;ApoE / mice and control littermates (n¼ 3–12). Data are means±s.e.m.; n and P values are indicated; *Po0.05, unpaired
two-tailed t test.
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Mcp1f/f;ApoE / mice fed with HFD for 2 months and we did
not observe any difference in the number of F4/80þ cells or in
the number of Ki67þ cells (Supplementary Fig. 3). Altogether,
these results suggest that nestinþ BMSCs regulate the egress of
inﬂammatory cells from the BM to circulation during early stages
of atherogenesis.
Mcp1 deletion in nestinþ cells delays atherosclerosis. The
egress of inﬂammatory cells from the BM towards circulation
represents a ﬁrst step in atherosclerosis as the main source of
inﬂammatory cells that later inﬁltrate the artery wall. To deter-
mine the effect of Mcp1 deletion in BMSC or BMEC on
atherosclerotic plaque formation, Nes-creERT2;Mcp1f/f;ApoE /
mice, Cdh5-creERT2;Mcp1f/f;ApoE / mice and control
Mcp1f/f;ApoE / mice were fed with HFD for 2 months. After
this period, their aortas were stained with Oil Red O to mark lipid
accumulation in the artery wall. Planimetric measurements of
atherosclerotic lesions were conducted in two regions: the thor-
acic aorta and the aortic arch, which contains the three main
bifurcations exhibiting turbulent blood ﬂow, resulting in more
abundant and larger atherosclerotic plaques.
Consistent with less substantial changes in the number of
circulating inﬂammatory cells in mice with Mcp1 deletion in
endothelial cells, atherosclerosis progressed similarly in these
mice and their control littermates: 2 months after feeding the
mice with HFD, the number and size of atherosclerotic lesions in
the aorta of mice with Mcp1 deletion in endothelial cells
remained unchanged (Fig. 2a,b; Supplementary Fig. 4a–c). In
contrast—and unexpectedly—, the number and size of aortic
atherosclerotic lesions was 2–4-fold decreased in mice lacking
Mcp1 in nestinþ cells (Fig. 2c,d; Supplementary Fig. 4d–f),
despite the increased number of circulating inﬂammatory cells in
these mice. Together, these results indicate that Mcp1 deletion in
nestinþ cells—but not in endothelial cells only—delays
atherogenesis.
Mcp1 from nestinþ cells directs aortic inﬂammatory inﬁltration.
Consistently with unchanged atheroma progression in mice with
Mcp1 deletion in endothelial cells (Fig. 2a,b), the frequency of
CD45þ , CD11bþ Ly6Ghigh and CD11bþ Ly6Chigh unchanged,
despite a speciﬁc 50% reduction in Mcp1 mRNA expression in
the aorta of experimental mice (Supplementary Fig. 5).
Previous studies have correlated directly circulating inﬂamma-
tory cells with atherogenesis35. On the contrary, a transient
increase in circulating inﬂammatory following Mcp1 deletion in
nestinþ cells correlated with delayed atheroma plaque formation
in these mice. Therefore, we hypothesized that inﬂammatory
inﬁltration in the aorta might also depend on Mcp1 produced
locally by nestinþ cells.
Inﬂammatory inﬁltration starts with the adhesion and recruit-
ment of circulating inﬂammatory neutrophils and monocytes
through adhesion molecules1,2. Soon after tamoxifen
administration, Mcp1 mRNA expression—but not Cxcl12 or
Icam1 expression— was 2-fold reduced in the aorta of mice with
Mcp1 deletion in nestinþ cells (Fig. 3a–d). Consistent with
unchanged expression of adhesion molecules, the number of
rolling leukocytes or their velocity, measured by intravital
microscopy of the carotid artery, remained unaffected 3 or 5
weeks after HFD (Supplementary Fig. 6; Supplementary Movies 1
and 2). However, the frequency of CD45þ hematopoietic cells,
CD11bþ Ly6Ghigh inﬂammatory neutrophils and CD11bþ
Ly6Chigh inﬂammatory monocytes was 3–4-fold reduced in the
aortas of Nes-creERT2;Mcp1f/f;ApoE / mice, compared with
control Mcp1f/f;ApoE / mice that were also treated with
tamoxifen and fed with HFD for 2 months (Fig. 3e–i). Therefore,
we performed adoptive transfer experiments to determine
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whether leukocyte migration into the aorta might be compro-
mised in mice lacking Mcp1 in nestinþ cells. We transplanted
Gr1þ BM leukocytes and peripheral blood mononuclear cells,
obtained from CD45.1 mice fed with HFD for 2 months,
into (CD45.2) Nes-creERT2;Mcp1f/f;ApoE / mice and control
Mcp1f/f;ApoE / littermates (Fig. 3j). Flow cytometry analyses
performed 14–18 h later showed accumulation of CD45.1þ cells
in the circulation of mice lacking Mcp1 in nestinþ cells. This was
associated with 2-fold-reduced frequency of CD45.1þ cells in the
aorta of these mice (Fig. 3k,l). These results suggest that nestinþ
cells regulate the inﬂammatory response in atherosclerosis
through Mcp1 production in two different compartments.
Whereas nestinþ BMSCs regulate the egress of inﬂammatory
cells to circulation, nestinþ residing in the aortic wall might
regulate inﬂammatory inﬁltration. Therefore we studied the
possible contribution of nestinþ cells residing in the artery wall
to atheroma plaque formation.
Nestinþ stromal and endothelial cells in the atheroma plaque.
Consistent with a previous study36, immunoﬂuorescence of aortic
sections of Nes-gfp mice showed the presence of GFPþ cells that
were distinct from vascular smooth muscle cells in the media and
the adventitia, where they were more abundant (adventitia,
23±6%; media, 8±3%) (Fig. 4a,b). In the aortic valves,
Nes-GFPþ cells were closely associated with CD31þ
endothelial cells of the aortic leaﬂets (Fig. 4c). Control isotype
antibodies demonstrated the speciﬁcity of anti-GFP antibodies
used to circumvent the reportedly high autoﬂuorescence
of aortic smooth muscle (Fig. 4d–f). Aortic Nes-GFPþ cells
were enriched inMcp1 and endogenous Nestin mRNA expression
(Supplementary Fig. 7a). Also, Mcp1 mRNA levels were much
higher in the aorta than in the BM, both in steady state
and 5 weeks after HFD (Supplementary Fig. 7b). Recent studies
have reported the expression of NESTIN in human blood
vessels37 and in atheroma plaque neovessels38. To further
investigate the relationship of MCP1-producing cells with
nestinþ cells residing in the wall of large human arteries, we
performed NESTIN and MCP1 immunohistochemistry in
consecutive cross sections from human coronary and carotid
arteries. MCP1 and NESTIN expression showed a high degree of
overlap in human atherosclerotic arteries (Fig. 4g–j;
Supplementary Fig. 7c–f).
Approximately 20% aortic Nes-GFPþ cells were CD45- Sca1þ
stromal cells (Supplementary Fig. 8)—a cell population with
progenitor features previously shown to contribute to atheroma
plaque formation23. To study the contribution of nestinþ cells
residing in the artery wall to atherogenesis we intercrossed
Nes-gfp mice with ApoE / mice. In adult Nes-gfp mice fed with
chow diet, onlyB2% of the CD45 Ter119 aortic stromal cells
expressed GFP; however, this frequency increased 430-fold in
Nes-gfp;ApoE / mice fed with HFD for two months (Fig. 5a).
Immunoﬂuorescence of GFP in brachiocephalic artery sections
showed nestinþ cells mainly located inside the atheroma
plaque and in the ﬁbrous cap (Fig. 5b). We further studied
the contribution of nestinþ cells to atheroma plaque forma-
tion through lineage-tracing experiments using Nes-CreERT2;
ApoE / mice intercrossed with RCE:loxP mice, which express
the R26R CAG-boosted EGFP (RCE) reporter allele harbouring
a loxP-ﬂanked STOP cassette39. We injected Nes-CreERT2;
ApoE / ;RCE:loxP mice with tamoxifen and fed them with
HFD for 8 weeks (Fig. 5c). Whole-mount immunoﬂuorescence of
the aortas showed GFPþ cells, different from smooth muscle cells,
invading the atheroma plaque from the outer layers of the artery
wall (Supplementary Fig. 9a–c; Supplementary Movie 3). Some
Nes-CreERT2-traced cells co-localized with CD31þ endothelial
cells (Fig. 5d; Supplementary Fig. 9d–I; Supplementary Movie 4),
whereas other Nes-CreERT2-traced cells expressed the
mesenchymal marker vimentin (Fig. 5e). Flow cytometry analysis
conﬁrmed the contribution of nestinþ cells to CD45 Ter119
Pdgfraþ mesenchymal cells and CD45 Ter119 CD31þ
endothelial cells in the atherosclerotic aorta (Fig. 5f).
To further verify that both nestinþ cell derivatives contribute
to Mcp1 production in the artery wall, we used a transgenic line
expressing GFP under the regulatory elements of the Mcp1
gene27. Endogenous Mcp1 mRNA expression was 15-fold higher
in GFPþ cells than in GFP cells isolated from the aorta of these
mice (Supplementary Fig. 10a). We intercrossed Mcp1-gfp mice
with ApoE / mice. Consistent with our previous ﬁndings,
GFPþ cells were detected in the atheroma plaque of
Mcp1-gfp;ApoE / mice fed with HFD for 8 weeks
(Supplementary Fig. 10b). To further deﬁne this stromal
contribution, Mcp1-gfp;ApoE / mice were lethally irradiated,
transplanted with ApoE / BM cells and fed with HFD for
8 weeks once recovered from transplantation (Supplementary
Fig. 10c). Flow cytometry analysis conﬁrmed the absence of
residual monocytes expressing Mcp1-GFP and the presence of
GFPþ non-hematopoietic stromal cells in the atherosclerotic
aorta. Consistent with our lineage-tracing studies using
Nes-CreERT2 mice, B20% Mcp1-GFPþ cells expressed CD31
andB30% were Vcam1þ (Supplementary Fig. 10d–g). Together,
these results indicate that, during atherogenesis, nestinþ cells
increase in the atheroma plaque, where they locally guide
inﬂammatory inﬁltration through Mcp1 production.
Delayed calciﬁcation in animals lacking Mcp1 in nestinþ cells.
At more advanced disease stage, the atheroma plaque frequently
undergoes calciﬁcation9—a process largely inﬂuenced by the
inﬂammatory inﬁltration, both in atherosclerosis and in aortic
valve disease40,41. Consistent with unchanged atheroma
progression in mice lacking Mcp1 in endothelial cells
(Fig. 2a,b), these mice exhibited unaltered aortic CD68þ
macrophage inﬁltration, plaque formation and calciﬁcation
in the aortic valves (Supplementary Fig. 11). In contrast—
consistently with the ﬂow cytometry analysis (Fig. 3g–i)—mice
lacking Mcp1 in nestinþ cells exhibited delayed aortic inﬁltration
by CD68þ macrophages, correlated with retarded collagen
deposition in the aortic valves of mice lacking Mcp1 in
nestinþ cells (Fig. 6a,b; Supplementary Fig. 12a,b). We
measured plaque calciﬁcation by ex-vivo microtomography
(mCT) of the hearts and aortas of Nes-creERT2;Mcp1f/f;ApoE /
mice and Mcp1f/f;ApoE / controls fed with HFD for 8–12
weeks. Whereas 70% of control mice showed macroscopic
calciﬁcation, this was detectable only in 30% of the mice
lacking Mcp1 in nestinþ cells (Fig. 6c,d). Calcium deposits
stained with Von Kossa were more abundant in the aortic leaﬂets.
Notably, the calciﬁed area of the aortic valves was 20-fold reduced
in mice lacking Mcp1 in nestinþ cells (Fig. 6e,f). This was
associated with B3-fold reduced CD68þ macrophages,
frequently localized near calciﬁed areas of the aortic leaﬂets
(Fig. 6g,h), where Mcp1-expressing stromal cells were also found
(Supplementary Fig. 12c–f).
Altogether, these results suggest that nestinþ stromal cells
regulate inﬂammatory inﬁltration in the atherosclerotic plaque
through Mcp1 production and point towards a crosstalk between
inﬂammatory cells and stromal cells during atheroma plaque
formation.
Discussion
Several studies support the idea that atherosclerosis is a
consequence of imbalanced lipid metabolism and a maladaptive
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms12706
6 NATURE COMMUNICATIONS | 7:12706 | DOI: 10.1038/ncomms12706 | www.nature.com/naturecommunications
immune response. However, the mechanisms that direct
inﬂammatory migration from the lymphoid organs to the
aorta—where they contribute critically to the atheroma plaque
formation—are not fully understood. Particularly, whether
stromal cells regulate inﬂammatory cell trafﬁc in chronic
inﬂammatory diseases (such as atherosclerosis) and/or participate
in atherosclerotic plaque formation has remained unknown. The
present study demonstrates that nestinþ stromal cells direct
inﬂammatory cell migration in different compartments as a
critical initial step in atherosclerosis. It also suggests that Mcp1
expression by stromal cells residing in different organs is a
gatekeeper, directing the trafﬁc of inﬂammatory cells during
chronic inﬂammation.
A recent report has suggested that nestinþ cells found in the
adventitia layer are multipotent36. Our results in ApoE / mice
fed with HFD show that BM nestinþ cells regulate the egress of
inﬂammatory monocytes and neutrophils. In the aorta of these
mice, nestinþ stromal cells, residing mainly in the adventitia,
increased B30 times during atherogenesis and contributed to
endothelial cells in the atherosclerotic plaque. Mcp1 deletion in
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nestinþ cells—but not in endothelial cells only—increased
circulating pro-inﬂammatory monocytes and neutrophils, but
decreased their aortic inﬁltration (without affecting leukocyte
adhesion to endothelium), delayed atheroma plaque formation
and aortic valve calciﬁcation. Therefore, these results suggest
that nestin expression marks stromal and endothelial cells
that systemically regulate inﬂammatory cell migration in
atherosclerosis.
Interestingly, this side-by-side comparison of the speciﬁc
contribution of endothelial and stromal cells has uncovered
important differences between acute and chronic inﬂammation.
Previous studies showed that, in acute inﬂammation, Mcp1
produced by both endothelial cells and mesenchymal progenitors
is required to redistribute inﬂammatory monocytes in the
BM (during minutes-hours after lipopolysaccharide (LPS)
administration/infection), and facilitate their mobilization in
Pdgfrα
Gated on CD45– Ter119– GFP+
5%
CD31
Co
un
t
6
15
10
5
0
5
4
3
2
1
0
0 102 103 104 105 103 104 105–1,180
–
10
2 0102
–
10
2–758
26%
c
α-CD31
α-GFP
8 w
High-fat diet
Nes-cre ERT2; RCE:loxP;
ApoE –/–
IHC analysis
FACS analysis
Nes-gfp
Co
un
t
a
1.7%
Gated on CD45– Ter119–
200
150
100
50
0
0102 103 104 105–272
–
10
2
GFP
Co
un
t
65%
Nes-gfp ;
ApoE –/–
f
d
α-vimentin
GFP α-GFP
Lumen
Gated on CD45– Ter119–
GFP
b
GFP
α-GFP
Dapi
Dapi
α-GFP α-vimentin
α-GFP
2aryAb
Dapi
2aryAb
e
Lumen
2ary Ab
80
15
70
60
180
40
30
5
20
10
0
0102 103 104 105
–
10
2–333
Figure 5 | Nestinþ cells participate in the formation of the atheroma plaque. (a) Flow cytometry of aortic stromal cells showing GFP expression in
Nes-gfp mice fed with chow diet (left panel) and in Nes-gfp;ApoE / mice fed with HFD for 2 months (right panel). (b) Representative GFP
immunoﬂuorescence of a section of the brachiocephalic artery branching out of the aortic arch of Nes-Gfp;ApoE / mice fed with HFD for 2 months.
Abundant GFPþ cells were found in the atheroma plaque and the adventitial layer. GFP was detected with an anti-GFP antibody (red). Nuclei were
counterstained with DAPI (blue). (c) Experimental design of lineage-tracing studies. Nes-creERT2;Rosa26-Gfp;ApoE / mice were injected with tamoxifen
to trace the progeny of nestinþ cells and were fed with HFD for 2 months. (d) Immunoﬂuorescence of the aortic valves using anti-GFP and anti-CD31
antibodies. Nuclei were counterstained with DAPI (blue). Inset, higher magniﬁcation of aortic leaﬂet. (e) Immunoﬂuorescence of the aortic valves with anti-
vimentin antibody. Nuclei were counterstained with DAPI (blue). (f) Flow cytometry histogram showing Pdgfra and CD31 expression in aortic CD45
Ter119 GFPþ cells. The frequencies of depicted populations are indicated. (b–e) Scale bar, 100mm.
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms12706
8 NATURE COMMUNICATIONS | 7:12706 | DOI: 10.1038/ncomms12706 | www.nature.com/naturecommunications
response to pathogens27. This seems to be different during
chronic inﬂammation, since the present study shows that Mcp1
deletion in endothelial and mesenchymal cells differentially
impacts the trafﬁc of inﬂammatory cells. Mcp1 deletion in
mesenchymal progenitors does not prevent this mobilization in
atherosclerosis but, instead, it increases circulating inﬂammatory
cells. It is important to note that both studies have markedly
distinct kinetics (from minutes-hours to weeks-months) and
different inﬂammatory stimuli (LPS injection versus high level of
blood cholesterol content in ApoE / mice fed with HFD).
Therefore, the response of endothelial and stromal cells might
depend on the nature of the inﬂammatory stimuli and the role of
these cells might also vary during acute and chronic
inﬂammation. Our results in atherosclerosis are consistent with
the overall chemotactic role of Mcp1 in various compartments
and point towards a gatekeeper function of this chemokine
expressed by nestinþ cells.
We previously showed that sympathetic efferent activity in the
BM regulates the trafﬁc of hematopoietic stem cells by activating
b3-adrenergic receptors expressed in BMSCs26,42. Following
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myocardial infarction, this mechanism has been shown to
relocate hematopoietic progenitors from the BM to the spleen
as a source of inﬂammatory cells that aggravate atherosclerosis43.
In our study, Mcp1 produced by nestinþ cells seem to
preferentially regulate the migration of inﬂammatory cells in
the BM and the aorta, rather than in the spleen. A very recent
study has identiﬁed CCR2þ hematopoietic progenitor cells as the
main primitive population mobilized in this context44. It would
be interesting to determine in future studies whether nestinþ
cells regulate the migration of CCR2þ HSPCs during chronic
inﬂammation.
We have shown here that nestinþ cells in different tissues
direct inﬂammatory cell migration through Mcp1 production: in
the BM they regulate the trafﬁc of inﬂammatory cells towards
circulation, whereas in the artery wall they direct inﬂammatory
inﬁltration. It is also important to note that chemokines typically
function in short distance ranges and therefore, not only the
amount of Mcp1 produced, but also the source location might
importantly determine monocyte attraction and migration.
Moreover, the mechanisms underlying Mcp1-regulated trafﬁc of
inﬂammatory cells are not yet fully elucidated, with different
possible non-exclusive mechanisms45.
To our knowledge, our study also represents the ﬁrst example
of high circulating inﬂammatory cells inversely (instead of
directly) correlating with atherosclerosis burden. In previous
studies, increased circulating inﬂammatory cells (monocytosis)
have invariably correlated directly with atherosclerosis progres-
sion34,35,46. In contrast, a transient increase in circulating
inﬂammatory cells did not promote atherosclerosis in our study
but, on the contrary, it delayed atheroma plaque formation.
A likely explanation is that the most relevant source of Mcp1 in
atherosclerosis is the nestinþ cell population residing in the
aorta. This contention is supported by the following data: (a)
Mcp1 expression levels were higher in the aorta than in the BM,
both in steady state and after 2 months in HFD; (b) nestinþ cells
are the main source of Mcp1 in the aorta and this aortic cell
population expands by 30-fold during atherogenesis; (c) Mcp1
deletion in nestinþ cells decreased inﬂammatory inﬁltration in
the aorta; (d) Mcp1 deletion in nestinþ cells quickly reduces the
levels of the chemokine in the aorta. Although these differences
disappear after 2 months in HFD (probably because other
Mcp1-producing cells, like monocytes, accumulate in the plaque),
they are sufﬁcient to cause a marked delay in atherosclerosis
progression.
Inﬂammation can compromise the integrity of endothelial cells
in vasa vasorum14, contributing to plaque haemorrhage18,47,48.
One study has shown that vasa vasorum expansion precedes
vessel wall thickening and plaque development49, whereas others
have suggested that inﬂammatory inﬁltration starts in the
adventitia layer, and later extends to the intima11,12. Several
studies have found vascular progenitor cells residing in the
adventitia. Among them, multipotent pericytes associated with
microvessels can differentiate into mesodermal and endodermal
cell lineages, including smooth muscle cells and ﬁbroblasts23,50.
Tissue resident endothelial progenitors have also been detected in
different blood vessels51,52. Our ﬁndings are consistent with these
studies, since nestinþ cells in the artery wall expanded
dramatically in ApoE / mice fed with HFD and included
both mesenchymal stromal cells and endothelial cells integrated
in these neovessels. Whether both lineages are derived from
common or different progenitors remains to be determined.
Overall, our side-by-side comparison suggests that Mcp1
production by the stromal cells (rather than endothelial cells) is
key in directing inﬂammatory cell trafﬁc in atherosclerosis.
Monocyte inﬁltration can trigger plaque calciﬁcation53,54 and
disruption of the Mcp1–Ccr2 axis reduces calciﬁcation in human
carotid arteries55. Therefore, the reduced aortic inﬂammatory
inﬁltration in mice lacking Mcp1 in nestinþ cells might explain
also the decreased vascular calciﬁcation in these mice as a result
of the overall delay in the atherosclerotic process in these mice. In
support of this possibility, we found calcium deposits in close
proximity of inﬂammatory cells in the aortic leaﬂets. Of note,
MCP1 and NESTIN expression largely overlapped in human
atherosclerotic arteries, suggesting that similar mechanisms might
take place in humans.
Altogether, this study highlights the relevance of nestinþ cells
in directing inﬂammatory cell migration during the early stages of
atherosclerosis, possibly applicable to other chronic inﬂammatory
diseases.
Methods
Mice. Animals used in this study included Mcp1f/f (ref. 27) Mcp1-gfp27, Nes-gfp31,
Nes-creERT2 (ref. 32), RCE:loxP (ref. 39), Cdh5-creERT2 (ref. 33), ApoE / (ref. 4)
and CD45.1 and CD45.2 C57BL/6 mice (Jackson Laboratories). All the mice were
bred in speciﬁc pathogen-free facilities. Mice of both genders (sex-matched) from
6 to 8 weeks of age were fed with atherogenic high-fat diet (HFD: 10, 8% total fat,
0.75% cholesterol; S8492, Ssniff, Germany) for the indicated time periods.
Compound NesCreERT2 mice, Cdh5-creERT2 mice and control littermate mice were
injected with tamoxifen (140mg kg 1 in corn oil, intraperitoneal) three times on
alternate days. The treatment was repeated monthly. Experimental procedures were
approved by the Animal Care and Use Committees of the Spanish National
Cardiovascular Research Center and Comunidad Auto´noma de Madrid (PA-47/11
and ES280790000176; Real Decreto RD53/2013). Mice were genotyped using
proteinase K at 10mgml 1 in proteinase K buffer (100mM Tris–HCl, pH 8,
100mM EDTA, 250mM NaCl) 3 h at 55 C. Genomic DNA were extracted
precipitating with isopropanol. DNA was washed with ethanol 70% and
resuspended in TE buffer. 1 ml was used to the PCR. The sequences of the primer
pairs used are listed in the Supplementary Table 1.
Irradiation and transplantation. Lethally irradiated (137Cs source, 12Gy whole
body irradiation, split dose 6þ 6Gy, 3 h apart) mice were transplanted the same
day with 2 106 BM nucleated cells from adult donor mice. Animals were allowed
to recover from transplantation for one week, after which they were fed with HFD
for 8 weeks.
Imaging. Confocal images of ﬂuorescent signals were acquired with a laser
scanning confocal microscope (Zeiss LSM 700, 25 /0.85 or Leica SP5 20 /0.7,
40 /1.25,  63/1.4). Optical z-stack projections were generated with the Zen2011
software package (Zeiss, Germany) using a maximal intensity algorithm or with
LAS software for Leica images. For quantiﬁcation, images were post- processed and
analyzed using ImageJ56.
lCTanalyses. Ex-vivo CT imaging of whole hearts connected to the thoracic aorta
was performed using a nanoPET/CT small-animal imaging system (Bioscan,
Washington DC, USA) equipped with an micro-focus X-ray source and a high-
resolution radiation-imaging device featuring a 1,024 3,596 pixel photodiode
array with 48mm pixel pitch. For CT measurements, scan parameters were 360
projections per rotations, 45 kV (peak) 145mA current, and a detector pixel size of
71 mm. Acquisition and reconstruction were performed with proprietary Nucline
software (Mediso, Budapest, Hungary).
Real-time RT-PCR. The mRNA was extracted from cells isolated by FACS using
the Dynabead mRNA Direct kit (Invitrogen). Whole aorta tissue was homogenized
using a tissue-lyser machine (Qiagen). Brieﬂy, samples were frozen with liquid
nitrogen and were homogenized with the tissue-lysser for 2min and frozen again in
liquid nitrogen. This procedure was repeated four times. Whole aorta RNA was
extracted using Tri Reagent (Sigma-Aldrich), followed by RNA puriﬁcation with
the RNeasy mini kit (Qiagen). Reverse transcription of 500 ng RNA was performed
using the High-Capacity cDNA Reverse Transcription kit (Applied Biosystems).
QPCR experiments were conducted using SYBR Green (Applied Biosystems).
Samples were loaded on a 384-well plate and analyzed on a 7900HT machine
(Applied Biosystems). The expression level of each gene was determined using the
relative standard curve method. The standard curve was performed using serial
dilutions of mouse reference total RNA (Clontech). The expression level of each
gene was calculated by interpolation from the standard curve. All values were
normalized with Gapdh and Hprt1 as endogenous housekeeping genes. The
sequences of the primer pairs used are listed in the Supplementary Table 1.
Histology. Maximov’s hematoxylin staining was performed in deparafﬁnized
sections after re-hydration. Nuclei were stained with the Mayer’s hematoxylin
solution for 15min, followed by overnight incubation in eosin Y/Azur II solution
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for cytoplasm staining. After rinsing brieﬂy in distilled water, sections were quickly
dehydrated in ethanol (70, 95 and 100%) and xylene. Slides were mounted in DPX.
Thricromic staining of the Masson protocol was used for atherosclerotic plaque
visualization. Cryopreserved sections were washed with PBS and ﬁxed in Bouin
solution for 1 h, washed with tap water (5min, twice) and stained with weigert’s
hematoxylin for 8min, tap water washed and a dipped in acidiﬁed water, followed
by staining with Biebrich–Scarlet solution for 7min. After washing with distilled
water, we incubated the sections for 5–10min in phosphomolybdic acid 5% and
washed them with distilled water. The sections were impregnated in fast green or
aniline blue for 2min, dehydrated and mounted in DPX.
For Oil Red O staining, whole-mount aortas were ﬁxed with 2% parafor-
maldehyde o/n at 4 C and post-ﬁxed twice with 78% methanol for 5min. Next, the
aortas were incubated in 0.2% Oil Red O for 1h at room temperature (RT) in a shaker.
After washing twice with 78% methanol for 5min, the aortas were mounted on agar
plates using mini-pins. Images were acquired using a stereomicroscope (Olympus).
The extent of atherosclerosis was assessed in the aortic roots and the thoracic aorta by
quantifying the number and the size of lipid Oil Red Oþ lipids deposits.
For Von Kossa staining, cryopreserved sections were washed with PBS for
5min, oxidized with 0.2% aqueous potassium permanganate for 30min, washed
with water and bleached in 5% aqueous oxalic acid until they became white. The
sections were then incubated in 1% silver nitrate and exposed to a strong light
source for B1 h, until calcium deposits became dark brown or black. We washed
the sections 3 times with distilled water and incubated them with 2.5% sodium
thiosulfate for 5min. After several washes with distilled water, sections were
counterstained with 1% safranin O or 0.1% nuclear fast red for 1min, dehydrated
and mounted with DPX.
Immunoﬂuorescence and inmunohistochemistry. For immunoﬂuorescence
analyses, aorta sections, aortic valve sections or whole-mount aortas were stained
following standard procedures. Brieﬂy, cryopreserved sections were washed with
PBS for 5min. A blocking and permeabilization step was performed with TNB
solution (100mM Tris–HCl, 150mM NaCl, 0.5% blocking reagent (Perkin Elmer))
containing 0.05% Tween for 1 h. The sections were then incubated with different
primary antibodies: live-colors rabbit anti-GFP antibody (Biolegend, San Diego,
CA, USA), goat anti-GFP antibody (Abcam), antibodies against CD31 (BD Bios-
ciences), CD68 (AbD Serotec, bionova), F4/80 (AbD Serotec, bionova), Ki67
(Abcam) all of them used at 1:100 dilution in TNB buffer o/n at 4 C. For the
anti-vimentin antibody (Cell signaling) the dilution used was 1:200. Following
washes with 0.05% Tween in PBS, we incubated the sections with secondary
antibodies conjugated to Alexa555, Alexa488 (Molecular Probes, Eugene, OR,
USA), or with Cy3-conjugated anti-smooth muscle actin antibody (Sigma) at 1:200
dilution in TNB for 2 h at RT. Following washes with 0.05% Tween in PBS, the
sections were incubated with 40 ,6-diamidino-2-phenylindole (DAPI) (1:1,000
dilution of 5mgml 1 stock) for 10min at RT and covered with mounting medium
(Dako). Whole-mount aortas were blocked and permeabilized with 0.1% triton in
TNB buffer o/n at 4 C. After several washes with 0.1% triton in PBS, the aortas
were incubated with different primary antibodies at least for 24 h at 4 C in TNB
buffer. Following washes, whole-mount aortas were incubated with secondary
antibodies for 3 h at RT and covered with Mounting Medium (Dako).
For inmunohistochemistry, coronary and carotid arteries were collected from
freshly excised hearts during transplant operations and by endarterectomy
respectively at the Hospital de la Santa Creu i Sant Pau (HSCSP, Barcelona, Spain).
The study was approved by HSCSP Ethics Committee (12/007/1292) and was
conducted according to the Declaration of Helsinki. Written informed consent was
obtained from each patient. Specimens for immunohistochemical studies were
ﬁxed overnight in 4% paraformaldehyde/0.1M PBS (pH 7.4), embedded in parafﬁn
and cut into 3-mm-thick sections with a microtome (Jung RM2055, Leica). Sections
were incubated with antibodies against Nestin (1:100; OBT1610, AbD Serotec) or
MCP1 (1:50; ab9669, Abcam) in a Dako Autostainer Link 48 using the Dako
EnVision Flex kit and the EnVision FLEX Target Retrieval Solution, Low pH.
Colour was developed using 3,30-diaminobenzidine (DAB) and sections were
counterstained with haematoxylin. Negative controls, in which the primary
antibody was omitted, were included to test for non-speciﬁc binding.
Flow cytometry and ﬂuorescence-activated cell sorting. Bones (limbs, sternum
and spine) were crushed in a mortar, ﬁltered through a 40-mm mesh to obtain
single cell suspensions, and depleted of red blood cells by lysis in 0.15M NH4Cl
for 10min at 4 C. Spleen samples were homogenized and ﬁltered prior to lysis;
blood samples were directly lysed. Cells (1–2 106 cells per sample) were
incubated with the appropriate dilution (2–5 mgml 1) of ﬂuorescent antibody
conjugates and DAPI for dead cell exclusion, and analyzed on FACS Canto II
ﬂow cytometer (BD Biosciences, Franklin Lakes, NJ, USA). Data were analyzed
with DIVA software (BD Biosciences, Franklin Lakes, NJ, USA). The following
antibody conjugates were used: CD45-PE (30-F11) (1:200), CD45.1-PE-Cy7
(A20) (1:200), CD45.2-APC-Cy7 (104) (1:100), CD11b-Alexa647 (M1/70)
(1:200), Ly6C-FITC (AL-21) (1:200), Ly6G-PE (1A8) (1:200), Sca1-PE
(E13-161.7) (1:200), CD31-APC (MEC13.3) (1:100), CD140a-APC (APA5)
(1:100), Ter119-PE-Cy7 (1:200), Gr1-PE (RB6-85C) (1:200), VCAM1-PE (429)
(1:200). When needed, biotinylated antibodies were detected with APC-Cy7-
conjugated streptavidin (BD Biosciences) (1:100).
For BM cell sorting, bones (limbs, hips and sternum) were crushed in a mortar
and incubated with collagenase I (1mgml 1) (Sigma) for 1 h at 37 C with gentle
agitation. Collagenase I was inactivated with 2% FBS in PBS and the solution was
ﬁltered through a 40-mm mesh to obtain single cell suspensions. Red blood cells
were lysed in 0.15M NH4Cl for 10min at 4 C. Cells were stained with CD45
(1:200), Ter119 (1:200) and CD31 (1:100) antibodies. Populations of interest were
separated in a FACS Aria cell sorter (BD Bioscience). For ﬂow cytometry of
mouse aorta, several aortas were pooled, cut in small pieces and digested with
0.25mgml 1 liberase (Roche) in RPMI1640þ 10% FBS medium at 37 C for 1 h
with gentle agitation (300 r.p.m.). After this period we inactivated the liberase with
2% FBS in PBS solution. The suspension was ﬁltered through a 40-mm mesh to
obtain single cell suspensions that were directly stained for ﬂow cytometry analysis.
Intravital microscopy. Intravital microscopy was performed in the carotid artery of
live animals as previously described57. Brieﬂy, mice were anesthetized and were
injected with 50mg of rhodamine 6G (Sigma) that labels mononuclear peripheral
blood cells. After, mice were placed in decubitus position, and the carotid artery
exposed and carefully dissected. The bifurcation of the common left carotid artery is
susceptible to atherosclerosis in humans and mice and is easily accessible with minor
surgery. High-resolution in vivo images were acquired with this procedure that
allows vessel stabilization without signiﬁcantly compromising blood ﬂow. Images
were captured using a 40 NA 1.0 objective and the CoolSnap camera with 4 4
binning in Cy3 channel (1.7Hz). The number of rolling cells was determined by
counting the number of leukocytes crossing an imaginary line perpendicular to the
vessel during at least 30 s. Several ﬁelds (typically 5) were imaged from the carotid
bifurcation, or from the common carotid artery, and each data point represents one
ﬁeld. Although the appearance of plaques in the carotid artery is heterogeneous, for
visualization we chose areas prone to plaque development. Data were normalized to
the number of rolling cells per minute. Rolling velocity (in mms 1) was determined
by measuring time and distances travelled (B70mm) by individual leukocytes using
a digital caliper with the Slidebook software, (Intelligent Imaging Innovations), and is
shown as mms 1. Five to ten leukocytes were analyzed per ﬁeld and each data point
represents one leukocyte.
Data availability. The authors declare that the data supporting the ﬁndings of this
study are available within the article and its Supplementary information ﬁles.
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